A5057880586- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
- Multiple and Secondary Primary Cancers
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Nutritional Studies and Diet
- Global Public Health Policies and Epidemiology
- Global Health Care Issues
- Esophageal Cancer Research and Treatment
- Nutrition and Health in Aging
- COVID-19 and healthcare impacts
- Genetic factors in colorectal cancer
- Cervical Cancer and HPV Research
- BRCA gene mutations in cancer
- Alcohol Consumption and Health Effects
- Liver Disease Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Childhood Cancer Survivors' Quality of Life
- Gastric Cancer Management and Outcomes
- Acute Lymphoblastic Leukemia research
- Health disparities and outcomes
- Frailty in Older Adults
- Esophageal and GI Pathology
- Advances in Oncology and Radiotherapy
Centre International de Recherche sur le Cancer
2016-2025
World Health Organization - Pakistan
2021-2023
Cancer Council NSW
2019
UNSW Sydney
2019
Albert Einstein College of Medicine
2019
The University of Sydney
2019
Centre de Recherche en Cancérologie de Lyon
2017
Imperial College London
2016
Hellenic Health Foundation
2016
University of Ioannina
2016
Abstract This article provides an update on the global cancer burden using GLOBOCAN 2020 estimates of incidence and mortality produced by International Agency for Research Cancer. Worldwide, estimated 19.3 million new cases (18.1 excluding nonmelanoma skin cancer) almost 10.0 deaths (9.9 occurred in 2020. Female breast has surpassed lung as most commonly diagnosed cancer, with 2.3 (11.7%), followed (11.4%), colorectal (10.0 %), prostate (7.3%), stomach (5.6%) cancers. Lung remained leading...
Abstract This article provides a status report on the global burden of cancer worldwide using GLOBOCAN 2018 estimates incidence and mortality produced by International Agency for Research Cancer, with focus geographic variability across 20 world regions. There will be an estimated 18.1 million new cases (17.0 excluding nonmelanoma skin cancer) 9.6 deaths (9.5 in 2018. In both sexes combined, lung is most commonly diagnosed (11.6% total cases) leading cause death (18.4% deaths), closely...
Estimates of the worldwide incidence and mortality from 27 major cancers for all combined 2012 are now available in GLOBOCAN series International Agency Research on Cancer. We review sources methods used compiling national cancer estimates, briefly describe key results by site 20 large "areas" world. Overall, there were 14.1 million new cases 8.2 deaths 2012. The most commonly diagnosed lung (1.82 million), breast (1.67 colorectal (1.36 million); common causes death (1.6 deaths), liver...
Estimates of the worldwide incidence and mortality from 36 cancers for all combined year 2018 are now available in GLOBOCAN database, compiled disseminated by International Agency Research on Cancer (IARC). This paper reviews sources methods used compiling cancer statistics 185 countries. The validity national estimates depends upon representativeness source information, to take into account possible bias, uncertainty intervals provided estimated sex- site-specific all-ages number new cases...
Abstract This article presents global cancer statistics by world region for the year 2022 based on updated estimates from International Agency Research Cancer (IARC). There were close to 20 million new cases of in (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 deaths NMSC). The suggest that approximately one five men or women develop a lifetime, whereas around nine and 12 die it. Lung was most frequently diagnosed 2022, responsible almost 2.5 cases, eight worldwide (12.4% all...
<h3>Objective</h3> The global burden of colorectal cancer (CRC) is expected to increase by 60% more than 2.2 million new cases and 1.1 deaths 2030. In this study, we aim describe the recent CRC incidence mortality patterns trends linking findings prospects reducing through prevention care. <h3>Design</h3> Estimates sex-specific rates in 2012 were extracted from GLOBOCAN database. Temporal assessed for 37 countries using data <i>Cancer Incidence Five Continents</i> (CI5) volumes I–X WHO...
Our study briefly reviews the data sources and methods used in compiling International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics year 2020 summarises main results. National estimates were calculated based best available incidence from population-based registries (PBCR) mortality World Health Organization database. rates by sex age groups estimated 38 sites 185 countries or territories worldwide. There an 19.3 million (95% uncertainty interval [UI]: 19.0-19.6 million)...
The relative importance of cardiovascular disease (CVD) and cancer as leading causes premature death are examined in this communication. CVD now the 127 countries, with 70 countries (including Brazil India) 57 China). Such observations can be seen part a late phase an epidemiologic transition, taking place second half 20th century first present one, which dominance infectious diseases is progressively superseded by noncommunicable diseases. According to ranks recent trends, may surpass cause...
Abstract Contemporary information on the fraction of cancers that potentially could be prevented is useful for priority setting in cancer prevention and control. Herein, authors estimate proportion number invasive cases deaths, overall (excluding nonmelanoma skin cancers) 26 types, adults aged 30 years older United States 2014, were attributable to major, modifiable exposures (cigarette smoking; secondhand smoke; excess body weight; alcohol intake; consumption red processed meat; low...
<h3>Objective</h3> The two major histological types of oesophageal cancer—adenocarcinoma (AC) and squamous cell carcinoma (SCC)—are known to differ greatly in terms risk factors epidemiology. To date, global incidence estimates for individual subtypes are still lacking. This study the first time quantified burden cancer by subtype. <h3>Design</h3> Where available, data from Cancer Incidence Five Continents Vol. X (CI5X) were used compute, age-specific, sex-specific country-specific...
High body-mass index (BMI; defined as 25 kg/m(2) or greater) is associated with increased risk of cancer. To inform public health policy and future research, we estimated the global burden cancer attributable to high BMI in 2012.
ABSTRACT By using data from the International Agency for Research on Cancer publication Incidence in 5 Continents and GLOBOCAN, this report provides first consolidated global estimation of subsite distribution new cases lip, oral cavity, pharyngeal cancers by country, sex, age year 2012. Major geographically based, sex‐based, age‐based variations incidence were observed. Lip highly frequent Australia (associated with solar radiation) central eastern Europe tobacco smoking). Cancers cavity...
Objective Early-onset colorectal cancer (CRC) is increasing in the USA despite rapid declines older ages. Similar patterns are reported Australia and Canada, but a comprehensive global analysis of contemporary data lacking. Design We extracted long-term from Cancer Incidence Five Continents supplemental sources to report on worldwide CRC incidence rates trends by age (20–49 years ≥50 years) through diagnosis year 2012 or beyond (Australia, Finland, New Zealand, Norway, Sweden, USA). Results...
Cancer Incidence in Five Continents (CI5), a longstanding collaboration between the International Agency for Research on and Association of Registries, serves as unique source cancer incidence data from high‐quality population‐based registries around world. The recent publication Volume X comprises 290 covering 424 populations 68 countries registration period 2003–2007. In this article, we assess status worldwide, describe techniques used CI5 to evaluate their quality highlight notable...